ArticleAmerican journal of preventive cardiology2026
Quantifying population-level antihypertensive treatment eligibility under the 2025 AHA/ACC hypertension guideline: What has changed - And where the greatest opportunity remains.
Huanhuan Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it